Sign In
Buy BTMD
$2.11
-0.0400 (-1.86%)
At Close: Jun 03, 2026
Biote Provides Preliminary 2023 Results and Initial 2024 Guidance
04:05pm, Wednesday, 17'th Jan 2024
IRVING, Texas--(BUSINESS WIRE)--biote Corp. (NASDAQ: BTMD) (“Biote” or the “Company”), a leading solutions provider in preventive health care through the delivery of personalized hormone optim
Biote Names Robert Peterson as Chief Financial Officer
04:05pm, Thursday, 11'th Jan 2024
IRVING, Texas--(BUSINESS WIRE)--biote Corp. (NASDAQ: BTMD) (“Biote” or the “Company”), a leading solutions provider in preventive health care through the delivery of personalized hormone optim
biote Should Keep Delivering Strong Growth
11:34pm, Wednesday, 29'th Nov 2023
biote Corp. returned to profitability in Q3 2023 and is expected to continue to be profitable in the future. The company's growth is driven by the sale of hormone replacement therapy products and its
Biote Corp. (BTMD) Reports Q3 Loss, Lags Revenue Estimates
09:47pm, Tuesday, 07'th Nov 2023
Biote Corp. (BTMD) came out with a quarterly loss of $0.11 per share versus the Zacks Consensus Estimate of $0.08. This compares to loss of $0.09 per share a year ago.
Biote Reports Third Quarter 2023 Financial Results
04:45pm, Tuesday, 07'th Nov 2023
IRVING, Texas--(BUSINESS WIRE)--Biote (NASDAQ: BTMD), a leading solutions provider in preventive health care through the delivery of personalized hormone therapy, today announced financial results for
Biote Schedules Third Quarter 2023 Financial Results Release and Conference Call
08:30am, Tuesday, 24'th Oct 2023
IRVING, Texas--(BUSINESS WIRE)--biote Corp. (Nasdaq: BTMD) (“Biote” or the “Company”), a leading provider of hormone optimization, today announced the Company will provide third quarter financ
Biote Corp. (BTMD) Beats Q2 Earnings and Revenue Estimates
07:46pm, Thursday, 10'th Aug 2023
Biote Corp. (BTMD) came out with quarterly earnings of $0.44 per share, beating the Zacks Consensus Estimate of $0.10 per share. This compares to earnings of $0.27 per share a year ago.
Biote Reports Second Quarter 2023 Financial Results
04:30pm, Thursday, 10'th Aug 2023
IRVING, Texas--(BUSINESS WIRE)--Biote (NASDAQ: BTMD), a leading solutions provider in preventive health care through the delivery of personalized hormone therapy, today announced financial results for
Recent Price Trend in biote Corp. (BTMD) is Your Friend, Here's Why
10:35am, Tuesday, 18'th Jul 2023
If you are looking for stocks that are well positioned to maintain their recent uptrend, biote Corp. (BTMD) could be a great choice. It is one of the several stocks that passed through our "Recent Pri
biote Corp. (BTMD) Moves 5.3% Higher: Will This Strength Last?
10:21am, Wednesday, 12'th Jul 2023
biote Corp. (BTMD) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase
Biote Schedules First Quarter 2023 Financial Results Release and Conference Call
08:30am, Wednesday, 26'th Apr 2023
IRVING, Texas--(BUSINESS WIRE)--biote Corp. (Nasdaq: BTMD) (“Biote” or the “Company”), a leading provider of preventive health care through the delivery of personalized hormone therapy, today
Does biote Corp. (BTMD) Have the Potential to Rally 82.51% as Wall Street Analysts Expect?
11:31am, Friday, 31'st Mar 2023
The mean of analysts' price targets for biote Corp. (BTMD) points to an 82.5% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among ana
Biote Schedules Fourth Quarter and Full Year 2022 Financial Results Release and Conference Call
04:15pm, Thursday, 09'th Feb 2023
IRVING, Texas--(BUSINESS WIRE)--Biote Corp. (Nasdaq: BTMD) (“Biote” or the “Company”), a leading provider of preventive health care through the delivery of personalized hormone therapy, today
Biote Schedules Third Quarter 2022 Financial Results Release and Conference Call
08:30am, Monday, 31'st Oct 2022
IRVING, Texas--(BUSINESS WIRE)--biote Corp. (Nasdaq: BTMD) (“Biote” or the “Company”), a leading provider of preventive health care through the delivery of personalized hormone therapy, today
Biote to Report Second Quarter 2022 Financial Results on August 9, 2022 and Host Conference Call on August 10, 2022
11:00am, Wednesday, 20'th Jul 2022
IRVING, Texas--(BUSINESS WIRE)--biote Corp. (“Biote” or the “Company”) (Nasdaq: BTMD), a high growth, medical practice-building business within the hormone optimization space, will report its
